The profound clinical consequences of Gram-positive
toxic shock are hypothesized to stem from excessive Th1 responses to
superantigens. We used a new
superantigen-sensitive transgenic model to explore the role of TCRalphabeta T cells in responses to
staphylococcal enterotoxin B (SEB) in vitro and in two different in vivo models. The proliferative and
cytokine responses of
HLA-DR1 spleen cells were 100-fold more sensitive than controls and were entirely dependent on TCRalphabeta T cells.
HLA-DR1 mice showed greater sensitivity in vivo to two doses of SEB with higher mortality and serum
cytokines than controls. When d-
galactosamine was used as a sensitizing agent with a single dose of SEB,
HLA-DR1 mice died of
toxic shock whereas controls did not. In this sensitized model of
toxic shock there was a biphasic release of
cytokines, including
TNF-alpha, at 2 h and before death at 7 h. In both models, mortality and
cytokine release at both time points were dependent on TCRalphabeta T cells. Anti-
TNF-alpha pretreatment was protective against
shock whereas anti-IFN gamma pretreatment and delayed anti-
TNF-alpha treatment were not. Importantly, anti-
TNF-alpha pretreatment inhibited the early
TNF-alpha response but did not inhibit the later
TNF-alpha burst, to which mortality has previously been attributed. Splenic T cells were shown definitively to be the major source of
TNF-alpha during the acute
cytokine response. Our results demonstrate unequivocally that TCRalphabeta T cells are critical for lethality in
toxic shock but it is the early
TNF-alpha response and not the later
cytokine surge that mediates lethal
shock.